These final results, together with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the idea of targeting ACKR3 as a novel way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-associated Diseases. These benefits counsel that conolidine https://edmundd017gwl1.p2blogs.com/profile